AKT1 and cancer: TQ was found to chemosensitize gemcitabine against cancer cells in inducing apoptosis by inhibition of Akt/mTOR/S6 signaling pathways and reduced expression of antiapoptotic proteins [118], providing a strong rationale for the potentiating role of TQ with gemcitabine in GBM therapy [119].